MIRM
Mirum Pharmaceuticals Inc
NASDAQ: MIRM · HEALTHCARE · BIOTECHNOLOGY
$94.20
+0.21% today
Updated 2026-04-29
Market cap
$5.74B
P/E ratio
—
P/S ratio
11.02x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$40 – $109
Volume
0.8M
Mirum Pharmaceuticals Inc (MIRM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+78.2%
Last 4 quarters
Revenue YoY growth
+49.8%
Most recent quarter
EPS YoY growth
+75.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.4%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+15.4%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $-0.12 | -146.9% | $90.93 | $89.78 | -1.3% |
| 2025-11-04 | $0.05 | +133.3% | $70.85 | $70.09 | -1.1% |
| 2025-08-06 | $-0.12 | +63.6% | $51.84 | $59.82 | +15.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.05 | $-0.12 | -146.9% | $148.93M | +49.8% |
| 2025-09-30 | $-0.15 | $0.05 | +133.3% | $133.01M | +47.2% |
| 2025-06-30 | $-0.33 | $-0.12 | +63.6% | $127.78M | +64.1% |
| 2025-03-31 | $-0.48 | $-0.30 | +37.5% | $111.58M | +61.2% |
| 2024-12-31 | $-0.25 | $-0.49 | -98.7% | $99.41M | +42.9% |
| 2024-09-30 | $-0.45 | $-0.30 | +33.8% | $90.38M | +89.4% |
| 2024-06-30 | $-0.47 | $-0.52 | -10.6% | $77.88M | +107.7% |
| 2024-03-31 | $-0.48 | $-0.54 | -12.5% | $69.22M | +119.1% |
| 2023-12-31 | $-0.24 | $-0.66 | -175.0% | $69.55M | — |
| 2023-09-30 | $-0.63 | $-0.57 | +9.5% | $47.73M | — |
| 2023-06-30 | $-0.80 | $-1.94 | -142.5% | $37.50M | — |
| 2023-03-31 | $-0.94 | $-0.80 | +14.9% | $31.60M | — |
Frequently asked questions
Has Mirum Pharmaceuticals Inc beaten earnings estimates?
Mirum Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +78.2% over the last 3 quarters.
How does MIRM stock react to earnings?
MIRM stock has moved an average of +4.4% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Mirum Pharmaceuticals Inc's revenue growth rate?
Mirum Pharmaceuticals Inc reported year-over-year revenue growth of +49.8% in its most recent quarter, with EPS growing +75.5% year-over-year.